Carlsmed, Inc. (CARL)

Carlsmed Statistics

Total Valuation

Carlsmed has a market cap or net worth of $323.53 million. The enterprise value is $227.36 million.

Market Cap	323.53M
Enterprise Value	227.36M

Important Dates

The last earnings date was Thursday, November 6, 2025, after market close.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

Carlsmed has 26.58 million shares outstanding. The number of shares has increased by 120.50% in one year.

Current Share Class	26.58M
Shares Outstanding	26.58M
Shares Change (YoY)	+120.50%
Shares Change (QoQ)	+359.32%
Owned by Insiders (%)	11.73%
Owned by Institutions (%)	17.55%
Float	9.50M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.36
Forward PS	7.17
PB Ratio	3.07
P/TBV Ratio	3.05
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	5.08
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 12.03, with a Debt / Equity ratio of 0.17.

Current Ratio	12.03
Quick Ratio	11.59
Debt / Equity	0.17
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-17.56

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-20.94%
Revenue Per Employee	$502,854
Profits Per Employee	-$295,787
Employee Count	89
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	13.49
200-Day Moving Average	n/a
Relative Strength Index (RSI)	44.98
Average Volume (20 Days)	55,250

Short Selling Information

The latest short interest is 417,239, so 1.57% of the outstanding shares have been sold short.

Short Interest	417,239
Short Previous Month	360,350
Short % of Shares Out	1.57%
Short % of Float	4.39%
Short Ratio (days to cover)	2.61

Income Statement

In the last 12 months, Carlsmed had revenue of $44.75 million and -$26.33 million in losses. Loss per share was -$3.07.

Revenue	44.75M
Gross Profit	33.46M
Operating Income	-25.95M
Pretax Income	-25.74M
Net Income	-26.33M
EBITDA	-25.73M
EBIT	-25.95M
Loss Per Share	-$3.07

Balance Sheet

The company has $115.37 million in cash and $17.61 million in debt, giving a net cash position of $97.76 million or $3.68 per share.

Cash & Cash Equivalents	115.37M
Total Debt	17.61M
Net Cash	97.76M
Net Cash Per Share	$3.68
Equity (Book Value)	106.66M
Book Value Per Share	4.01
Working Capital	120.54M

Cash Flow

In the last 12 months, operating cash flow was -$27.86 million and capital expenditures -$630,000, giving a free cash flow of -$28.49 million.

Operating Cash Flow	-27.86M
Capital Expenditures	-630,000
Free Cash Flow	-28.49M
FCF Per Share	-$1.07

Margins

Gross margin is 74.76%, with operating and profit margins of -57.99% and -57.52%.

Gross Margin	74.76%
Operating Margin	-57.99%
Pretax Margin	-57.52%
Profit Margin	-57.52%
EBITDA Margin	-57.50%
EBIT Margin	-57.99%
FCF Margin	n/a

Dividends & Yields

Carlsmed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-120.50%
Shareholder Yield	-120.50%
Earnings Yield	-8.10%
FCF Yield	-8.76%

Analyst Forecast

The average price target for Carlsmed is $20.25, which is 66.39% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$20.25
Price Target Difference	66.39%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	51.15%
EPS Growth Forecast (5Y)	-34.10%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Carlsmed has an Altman Z-Score of 7.53 and a Piotroski F-Score of 2.

Altman Z-Score	7.53
Piotroski F-Score	2